OCERA THERAPEUTICS INC's ticker is OCRX and the CUSIP is 67552A108. A total of 26 filers reported holding OCERA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $813,000 | -6.7% | 713,169 | -5.0% | 0.00% | – |
| Q2 2017 | $871,000 | -38.4% | 750,942 | -30.5% | 0.00% | – |
| Q1 2017 | $1,415,000 | +287.7% | 1,079,750 | +521.3% | 0.00% | – |
| Q4 2016 | $365,000 | -68.0% | 173,793 | -59.6% | 0.00% | – |
| Q3 2016 | $1,141,000 | +46.8% | 430,624 | +5.3% | 0.00% | – |
| Q2 2016 | $777,000 | -34.6% | 408,835 | +1.2% | 0.00% | – |
| Q1 2016 | $1,188,000 | -0.1% | 403,935 | +6.0% | 0.00% | – |
| Q4 2015 | $1,189,000 | +2.1% | 381,225 | +3.5% | 0.00% | – |
| Q3 2015 | $1,164,000 | -14.2% | 368,322 | +3.1% | 0.00% | – |
| Q2 2015 | $1,357,000 | -16.3% | 357,253 | +3.8% | 0.00% | – |
| Q1 2015 | $1,621,000 | -12.1% | 344,293 | +18.9% | 0.00% | – |
| Q4 2014 | $1,844,000 | +28.5% | 289,484 | -1.1% | 0.00% | – |
| Q3 2014 | $1,435,000 | -9.4% | 292,836 | +41.3% | 0.00% | – |
| Q2 2014 | $1,584,000 | -27.4% | 207,311 | +0.2% | 0.00% | – |
| Q1 2014 | $2,183,000 | +7.0% | 206,911 | +31.7% | 0.00% | – |
| Q4 2013 | $2,041,000 | +114.6% | 157,093 | +39.9% | 0.00% | – |
| Q3 2013 | $951,000 | – | 112,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|